Football fans around the world were stunned when Real Madrid confirmed that Kylian Mbappé, its French captain and marquee signing, was hospitalized for an acute bout of gastroenteritis during the Club World Cup. Although Real Madrid had originally reported that he was absent for the initial match because of illness, there was a formal medical report that confirmed the extent of his illness and in-hospital treatment and tests he required.
Even though Mbappé is recovering now with specific medical treatment outside the hospital, his sudden health fright focused fresh public attention on a prevalent but poorly understood illness: acute gastroenteritis.
Gastroenteritis is the inflammation of the stomach and intestines that causes vomiting, diarrhea, cramps in the abdomen, and occasionally fever or muscle pain. Commonly called the "stomach flu," it is not caused by the flu virus and has nothing to do with respiratory infections. Rather, it is usually caused by infection or chemical irritants to the gastrointestinal (GI) tract. There are two main types:
Mbappé's illness is an acute gastroenteritis, which means the symptoms came on suddenly and intensely but would likely pass with good care.
The most prevalent reason for gastroenteritis is the intake of contaminated food or water. It is also spread by contact with infected people or surfaces they have contacted. Some typical situations include:
Though most individuals recover quickly, individuals with compromised immune systems—such as young children, elderly, or those with chronic diseases—are at a higher risk for developing complications like dehydration and extended illness.
Acute gastroenteritis usually presents with a combination of the following:
These symptoms typically occur within 1–3 days of contact with the infection and can last anywhere from 24 hours up to two weeks, depending upon the cause and the immune response of the patient.
In the Mbappé case, the symptoms were bad enough to need hospitalization, which is not usual but required for observation of dehydration, electrolyte disturbances, or ongoing vomiting.
The origin of gastroenteritis comes from the inflammatory reaction in the body from a threat within the gastrointestinal system. Pathogens or toxic chemicals entering the system will have the immune reaction summon inflammation to combat invaders and heal damage.
In a majority of instances, it is an acute and transient condition. But if the infection is especially virulent or if the immune system of the body is weakened, inflammation becomes intense, aggravating symptoms and necessitating medical attention. The most common offenders are:
For otherwise healthy people, acute gastroenteritis is usually self-limiting and resolves with rest and hydration. For elite athletes such as Mbappé, any alteration in the body's fluid and nutrient balance can have a profound impact on performance and recovery. The disease becomes more severe when:
In such instances, hospitalization is advisable—as in Mbappé's case—for rehydration, electrolyte balance, and observation.
Although not all gastroenteritis cases can be avoided, the risk may be drastically cut down by sensible and preventive hygiene practices. Here's how:
Hand washing with soap and water for 20 seconds or more, particularly before eating and after using the bathroom, is one of the best means of preventing the transmission of GI infections.
Do not cross-contaminate when handling food, thoroughly cook meat, and refrigerate perishables immediately. Wash fruits and vegetables before eating.
While traveling, use sealed bottled water, don't drink ice in beverages, and eat only cooked or packaged food to minimize the risk of "traveler's diarrhea."
Disinfect surfaces frequently in shared spaces such as gyms, bathrooms, or kitchens to stop the spread of infection.
Excessive alcohol or certain medications use can irritate the lining of the gut and lead to chemical gastroenteritis.
While Kylian Mbappé will soon return to action, his recent hospitalization is a reminder that even the best professional athletes are not beyond the reach of diseases such as gastroenteritis. It also emphasizes the value of early treatment and medical surveillance in more complicated instances.
For the general public, it is imperative that they know about the causes, symptoms, and prevention of gastroenteritis—particularly with increasing travel and food safety as an ongoing global issue. With the right information and good hygiene techniques, most instances of gastroenteritis can be prevented or treated at home. But learning when to seek assistance—such as Mbappé's medical team—is what can turn the tables.
Acute gastroenteritis is widespread, but its effect can be from mild disruption to severe health risk depending on how it is handled. As a world-class sportsman or an average person coping with day-to-day well-being, early recognition of the symptoms, fluid intake, and attention to food and hygiene safety can keep you one step ahead of this miserable but avoidable illness.
(Credit-yourbestiemisha/instagram)
“This is a warning specifically for parents” — Influencer Michael Brown recently released a video warning parents as well as others, about a potentially addictive drink that is easily available at gas stations in the US. He detailed how, during a casual visit to the gas station store for a beverage, he was approached by a young boy who asked him to buy ‘Feel Free’ for him. Despite being refused, the kid persisted and even tried lunging for Michael’s wallet, leaving him shaken up.
While paying at the counter, Michael recalled asking the shop cashier what ‘Feel Free’ was, to which she pointed at little blue bottles on the counter. She said people are so addicted to it that sometimes they visit 5–6 times a day to buy it — “It’s addictive and people lose their minds.” A quick look at the comments section of the post, which now has more than 9 million views on Instagram, had many people shocked at the severity of the drink and its consequences. Different healthcare professionals also detailed their experience with patients. “It’s Kratom! Have had patients with seizures because of this and also babies experiencing withdrawal from maternal use during pregnancy. It’s no joke,” commented Dr. Shilpa, MD, Child Neurologist and Development Specialist.
To know how many people are affected or it continues to affect, you do not have to look too far — a subreddit known as QuittingFeelFree, which has 5k members, and QuittingKratom with 52k members, are prime spots to get first-person accounts of people who struggled for years or months with their addictions.
In one of the stories, Jasmine Adeoye from Austin posted on TikTok that just a few months before June 2024, she drank several bottles of Feel Free a day and found that quitting it was not easy.
Last year, the production company of Feel Free also faced lawsuits, however, many people are not aware of the same. CBS News had reported that Botanic Tonics had also faced a class-action lawsuit filed in 2023. The lawsuit alleged that the company's marketing was misleading and targeted individuals with a history of addiction. In a statement, the company said it had "fallen short of the high standards of transparency" and implemented changes like enhanced labeling and age restrictions.
One of the main ingredients listed in the ‘Feel Free’ drinks is ground kratom leaves. Now a regular person would think — how bad can leaves be? — and consume the drink, but it’s these same leaves that are risky and can lead to severe addiction.
Native to Southeast Asia, the US Food and Drug Administration explains that it also carries the risk of addiction, seizures, and, in rare cases, death. Since kratom is unregulated in the U.S., some products are sold in highly concentrated forms and may contain contaminants like heavy metals and harmful bacteria.
The American Addiction Centers detailed how lower doses of kratom could help people increase energy and alertness, while higher doses could produce effects similar to that of opioid drug abuse. They detailed a 7-year study done from 2011–2017. The study pointed out how there were 1,800 calls to poison control centers about kratom, with most of those calls happening in the last two years of that period. Here are some things that can happen with unregulated use of kratom:
While it's not common, long-term and heavy kratom use can lead to addiction. People who stop using it suddenly might experience withdrawal symptoms that feel similar to the flu, such as nausea, vomiting, body aches, and chills.
The FDA has not approved kratom for any use. This means that kratom products are not regulated and can sometimes be contaminated with dangerous substances like heavy metals and harmful bacteria. The FDA has warned consumers not to use kratom and has seized shipments of kratom-containing products.
Taking kratom with other drugs or alcohol can be very dangerous. In rare but serious cases, this combination has led to severe side effects like liver damage and even death.
Overdosing on kratom alone is very rare. However, when it is combined with other substances, the risk increases. For example, a CDC report linked kratom to 152 deaths in 2016 and 2017, but other substances were involved in 87% of those cases.
Credits: Canva
Over the past few years, doctors and researchers have noticed a clear pattern: more young adults are being diagnosed with colorectal cancer—those under 50. On the surface, some of this surge can be credited to increased screening, especially following guideline updates that lowered the recommended starting age from 50 to 45. But deeper beneath those screening numbers lies a troubling reality: diagnoses among truly younger adults aren’t solely due to being screened earlier. That means we’re facing a bigger shift, one that demands fresh solutions.
In 2018, the American Cancer Society recommended colorectal cancer screening begin at age 45—five years earlier than before. In 2021, the US Preventive Services Task Force followed suit. Unsurprisingly, this led to a jump in early-stage diagnoses among 45-to-49-year-olds.
ACS data published in JAMA shows a steady increase in screening rates: from 20.8% in 2019 and 19.7% in 2021, rising to 33.7% in 2023 among that age group. A second ACS-led study tracked early-stage diagnosis rates—from 9.4 cases per 100,000 in 2019, to 11.7 in 2021, then 17.5 in 2022. That’s a 50% relative increase between 2021 and 2022. Experts note this trend largely reflects held-back cases being detected earlier thanks to broader testing.
But that doesn’t chalk up the entire story. Colon and rectal cancers have been increasing steadily in younger adults—those under 45—for decades. This early-onset rise began in the mid-1990s and includes late-stage diagnoses—not just early detection.
Doctors stress that while the decline in age recommendations helped some, it doesn’t explain the persistent rise in younger adults. In fact, research suggests annual case increases of 2–2.6% have occurred since 2012 among those under 50. In the 20–39 age group, incidence has been rising by around 1.6% per year since 2004.
More than 20% of colorectal cancer cases now occur in adults under 55—double the rate from the mid-1990s. Alarmingly, this early-onset trend is contributing to colorectal cancer becoming the leading cause of cancer death among younger men and the second-leading cause among younger women.
These are not always lifestyle-driven cases. Many patients are young, active, and with no known family history. As clinicians, many have expressed how unsettling it is to see so many seemingly healthy people presenting with aggressive tumors—and often at advanced stages.
Researchers are testing multiple theories—but none yet fully explain the rise:
Gut microbe toxins such as colibactin, produced by certain E. coli, are drawing attention. These toxins leave a specific DNA mutation fingerprint in early-onset tumors—over three times more common compared to cancers in older patients. Some studies suggest 15% of early-onset cases involve colibactin-driven mutations.
Diet- and lifestyle-related risks remain central: obesity, processed meats, low-fiber diets, sedentary behavior, refined sugar, insufficient sleep, and environmental pollutants. One prominent study links higher birth and adolescent BMI with increased colon cancer risk later in life. Even every additional kilogram at birth above normal is tied to 9% higher colorectal cancer risk.
Other suspected contributors include microplastics, antibiotic use, and artificial light exposure, although more conclusive evidence is pending.
Crucial to stopping this trend early is awareness. Here’s what to watch for—and not dismiss, even if you’re under 45:
Jessica Star of ACS—lead author on both new JAMA papers—warns, more than half of cases in younger adults occurred in those not yet eligible for screening. So symptoms matter, regardless of age. If you're dismissed with a benign diagnosis like hemorrhoids, consider a second opinion.
Screening matters. Most colorectal cancers begin as precancerous polyps, and removing these early saves lives. Current recommended options include:
Promising new research shows that mailing stool test kits directly to eligible adults dramatically increases completed screenings—even more than simply offering choice. Yet, screening is still underused: more than 1 in 3 adults aged 45 and older report not getting screened as recommended. To reduce personal risk:
If you’re under 50—or even nearing that threshold—understand this: colorectal cancer is no longer just a disease of older adults. While earlier screening through age-lowering guidelines has helped catch many early-stage cancers in 45–49-year-olds, it doesn’t address the underlying, persistent rise in true early-onset cancer.
The surge among younger adults signals something deeper—and possibly preventable—but only if we tackle it strategically. That means screening more women and men at the right age, investing in research, and making early testing easier and more equitable.
As expert researchers remind us, we’re not merely diagnosing more cancers—we’re getting better at catching them earlier. But to save more lives, identify root causes, and reverse these trends, we must remain proactive. Not just for our generation—but for all who follow.
One of the most common cancers in the world, it is the leading cause of cancer related deaths in the world. It accounts for the highest mortality rates among men and women. However, this has become a rising issue among women. A 2014 study published in the Seminars in Thoracic and Cardiovascular Surgery journal explained that historically lung cancer was mainly studied in men because it was very rare in women. However, as social habits changed and more women started smoking, the number of lung cancer cases in women increased. They mentioned that lung cancer often behaves differently in women than it does in men, especially in non-smokers. This review looks at these differences, including risk factors, how the disease develops, and treatment options.
In the United States, lung cancer is the second most common cancer in women and the top cause of cancer-related death. Here are some important statistics from 2012:
Smoking is still the biggest cause of lung cancer in women, responsible for 80-90% of cases. However, a significant number of women who get lung cancer have never smoked.
According to Lungevity, women often face delays and hurdles in getting a lung cancer diagnosis, which can worsen their chances of survival.
Women are less likely to seek help for early symptoms and can experience longer waiting times between initial doctor visits and a final diagnosis. This can allow the disease to progress before treatment even begins.
Many women are not offered lung cancer screening. A study found that women of color who are eligible for screening are six times less likely to be offered it than their male counterparts.
Even with recent updates to screening guidelines in the Center of Disease Control and Prevention, which now include people aged 50 and older and with a smoking history of at least 20 pack-years, many women still don't qualify. This is a major issue because a large number of women with lung cancer have a limited smoking history, which means they are often overlooked.
The impact of lung cancer on a woman's well-being is often ignored, yet research shows it's a significant burden.
Women with lung cancer have higher rates of depression and anxiety than men. This stress is often made worse by the stigma of the disease, with many women reporting judgmental comments about smoking, regardless of whether they have a smoking history.
Sexual health is often an overlooked part of cancer care for women. A study of 249 women with lung cancer found that 77% experienced moderate to severe sexual dysfunction. The women reported issues like fatigue and shortness of breath during intimacy, as well as vaginal dryness and pain.
A long-standing problem in healthcare is the low number of women in clinical trials. This makes it difficult to know how effective a treatment is for women specifically.
Women make up only 40% of participants in clinical trials for diseases that affect them, like cancer. For non-small cell lung cancer, this number has not changed much over the past two decades.
Women face extra challenges in participating in trials, such as being primary caregivers, which limits their time. There are also gender biases from doctors who may assume women are less interested in research.
The lack of female representation is a safety issue. One study found that women were 25% more likely to have severe side effects from cancer treatments, but another study found that they were less likely to report these issues.
© 2024 Bennett, Coleman & Company Limited